HaploX develops a genetic sequencing technology that helps to detect the circulation of tumor DNA sequencing for personalized cancer therapy.
Business Model:
Revenue: $2.5M
Employees: 11-50
Address: Rm1106, 1 Songpingshan Road
City: Shenzhen
State: guangdong province
Zip: 510852
Country: CN
HaploX develops a genetic sequencing technology that helps to detect the circulation of tumor DNA sequencing for personalized cancer therapy.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2022 | Series D | - |
CNCB Capital SBCVC CNCB Capital SBCVC |
1/2016 | Series A | 1 | $10M |
SBCVC SBCVC |
1/2018 | Series A | $32M |
SB China Venture Capital |
12/2017 | Series A | 3 | $32M |
Kexin Capital SBCVC Youchoose Capital Kexin Capital SBCVC Youchoose Capital |
6/2018 | Series B | 1 | $30.2M |
Shenzhen Capital Group Shenzhen Capital Group |
7/2022 | Series D | 2 | - |
CNCB Capital SBCVC CNCB Capital SBCVC |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|